What is viral shedding?

What is Viral Shedding?

Viral shedding is the release of infectious virus particles or viral genetic material (RNA/DNA) from an infected person's body into the environment through various body fluids, secretions, and excreta—including respiratory secretions, saliva, stool, urine, genital secretions, and skin lesions.

Core Concept

Viral shedding represents the period during which a person can potentially transmit infection to others. However, a critical distinction exists: the detection of viral nucleic acid (RNA or DNA) alone does not necessarily indicate the presence of infectious virus or transmission potential 1. The immune system can neutralize viruses through envelope lysis or particle aggregation, which prevents infection but leaves nucleic acid that degrades slowly over time 1.

Key Characteristics by Virus Type

Respiratory Viruses

For SARS-CoV-2, viral shedding patterns show:

• Peak shedding occurs within the first 5 days after symptom onset, with pharyngeal virus shedding reaching maximum levels around day 4 1
• In immunocompromised patients during the Omicron era, median shedding duration varies by condition: 9 days for non-B cell malignancies, 11 days for B-cell malignancies, and 16 days for transplant patients 2
• 25% of immunocompromised patients shed virus for ≥21 days, particularly those with B-cell depletion 2
• Infectious virus is rarely cultured from samples with RT-PCR cycle threshold >32, indicating that high Ct values suggest low viral replication and minimal infectivity 2

For influenza (LAIV), shedding occurs in 80% of young children for a mean of 7.6 days, and in 30% of adults aged 5-49 years, with duration inversely correlated with age 3. Maximal shedding occurs within 2 days of vaccination, and transmission rates are extremely low (0.6-2.9%) 3.

Herpes Viruses

HSV-1 and HSV-2 demonstrate frequent asymptomatic shedding:

• Occurs on approximately 3% of days in immunocompetent individuals 4
• Higher rates in HIV-infected persons and when measured by PCR versus culture 4
• Most horizontal and vertical HSV transmission occurs during unrecognized or asymptomatic shedding 4
• Asymptomatic shedding is defined as detection of HSV by culture, PCR, or antigen detection from clinical specimens without any clinical symptoms 5

Clinical Implications

Infectivity Assessment

The presence of viral shedding does not automatically equal infectiousness. Key factors include:

• Viral load magnitude: Higher viral loads correlate with greater transmission risk 6
• Detection method: Culture-positive samples indicate viable, infectious virus; PCR-positive samples may only reflect viral debris 1
• Time from symptom onset: Early infection typically has higher infectious potential 7
• Host immune status: Immunocompromised patients shed longer and may have prolonged infectivity 2

Infection Control Considerations

For household contacts of immunocompromised patients:

• Live attenuated influenza vaccine (LAIV) can generally be given to household members, except for those living with severely immunocompromised individuals (HSCT recipients within 2 months post-transplant, GVHD patients, or SCID patients) 3
• Immunocompromised patients should avoid handling diapers of rotavirus-vaccinated infants for 4 weeks post-vaccination 3
• Contact with persons who develop skin lesions after varicella or zoster vaccination should be avoided until lesions clear 3

Duration Patterns

Viral shedding duration varies significantly:

• SARS-CoV-2: Typically 9-16 days in immunocompromised hosts, with culture positivity declining steeply between days 5-9 2, 7
• HSV: Continuous low-level shedding with periodic reactivation 8
• Enterovirus (CVA6): Median 16 days, with >50% remaining PCR-positive beyond standard isolation periods 9

Common Pitfalls

1. Equating PCR positivity with infectiousness: Prolonged RT-PCR positivity (≥3 weeks) after clinical recovery typically indicates low viral loads, sampling variability, or viral debris—not active shedding of infectious virus 2

2. Ignoring immune status: Immunocompromised patients, particularly those with B-cell depletion, require extended precautions due to prolonged shedding 2

3. Overlooking asymptomatic shedding: Many viruses (HSV, influenza, SARS-CoV-2) can be transmitted during asymptomatic periods when individuals are unaware of infection 3, 4

4. Site-specific considerations: Different body sites may show different shedding patterns—respiratory samples may be positive while blood and urine remain negative 1